Header Logo
Newsletter Podcast
Log In
← Back to all posts

Lasting Relief, Better Outcomes—Plus What PRP Docs Are Doing Differently

Apr 29, 2025
Connect

Highlights

  • Today’s Research Article: Your go-to treatment just got outperformed—see why PRP is leading in joint relief.

  • Questions from the Field: Even if they’re under 65, it’s better to have the ABN signed—every time.

  • Let’s Get Down to Business: Educate, personalize, and document—keys to building a thriving PRP practice.

  • Come Join Us: Train smarter, connect deeper—your next breakthrough starts at a live event.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Platelet-Rich Plasma versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis: A Prospective Randomized Controlled Clinical Trial

Michael-Alexander Malahias, Leonidas Roumeliotis, Vasileios S. Nikolaou, Efstathios Chronopoulos, Ioannis Sourlas, and Georgios C. Babis

Read the full article here.

Summary:

This prospective randomized controlled trial by Malahias et al. compared intra-articular platelet-rich plasma (IA-PRP) injections with corticosteroid injections for treating early to moderate trapeziometacarpal (thumb base) arthritis. Over 12 months, patients receiving IA-PRP experienced significantly better outcomes in pain relief (VAS score), hand function (Q-DASH score), and satisfaction than those treated with corticosteroids. While both treatments showed improvement at 3 months, only the PRP group maintained and improved these benefits at 12 months, with 62.5% of PRP patients reporting mild pain vs. just 12.5% in the steroid group.

The study also demonstrated that patient satisfaction with PRP rose over time, reaching 69% at 12 months compared to only 12.5% in the steroid group. This sustained improvement is attributed to PRP’s biological effects, including anti-inflammatory properties and stimulation of cartilage repair. Given its longer-lasting relief and functional improvement, IA-PRP offers a superior non-surgical option for managing mild to moderate thumb arthritis compared to the short-lived effects of corticosteroids.

Doctor-to-Patient Talking Points for Choosing IA-PRP Over Steroids (with Evidence)

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP Wins Again — And How You Can Too
Highlights Live Today: Are Culture-Expanded Stem Cells Crossing the Line? Join Us Live for the Debate.  Add to your calendar and tune in at 5PM PST       Today’s Research Article: PRP Beats Splints in CTS Relief — One Injection, Six Months of Gains. Questions from the Field: Adipose for the Win: Cushioning Meniscus Tears with Precision. Let’s Get Down to Business: From Burnout to Breakthrou...
PRP Works. Say It Right. Learn It Live.
Highlights Today’s Research Article - PRP Outshines Shockwave Therapy in Tennis Elbow Recovery — Less Pain, More Strength, Higher Satisfaction. Questions from the Field - “Booster or Not?” — Dr. DeMers Shares Her 12-Month Check-in Strategy for Sustained PRP Relief. Let’s Get Down to Business - Turn Medical Jargon into Trust—Watch How Better Communication Builds Better Patient Outcomes. ...
PRP Beats Shockwave, Real Talk on Cartilage, and How To Master Patient Talks
Highlights Live Today: Join us live as Dr. McGee breaks down top-performing peptide stacks, ideal patient profiles, and how to overcome the biggest barriers to integrating peptides into your orthopedic practice.  Add to your calendar and tune in at 5PM PST       Today’s Research Article: PRP proves superior to shockwave therapy for hip bone death—offering longer-lasting pain relief and real...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.